Title Effect of Mycelial Extract of Clavicorona pyxidata on the Production of Amyloid β-Peptide and the Inhibition of Endogenous β-Secretase Activity in vitro
Author Tae-Hee Lee1, Young-Il Park2, and Yeong-Hwan Han1,3*
Address 1Department of Life Science, College of Natural Science, Dongguk University, Gyeongju 780-714, Republic of Korea, 2Department of Biology, Graduate School, Dongguk University, Seoul 100-715, Republic of Korea, 3Myco Co., Gyeongju, Gyeongbuk 780-921, Republic of Korea
Bibliography Journal of Microbiology, 44(6),665-670, 2006,
DOI
Key Words Alzheimer’s disease, amyloid β-peptide, amyloid precursor protein, β-secretase, Clavicorona pyxidata
Abstract Amyloid β-peptide (Aβ), which is a product of the proteolytic effect of β-secretase (BACE) on an amyloid precursor protein, is closely associated with Alzheimer’s disease (AD) pathogenesis. There is sufficient evidence to suggest that a BACE inhibitor may reduce Aβ levels, thus decreasing the risk of AD. In a previous study, an extract of Clavicorona pyxidata DGUM 29005 mycelia was found to inhibit the production of a soluble β-amyloid precursor protein (sβAPP), Aβ, and BACE in neuronal cell lines. We sought to determine whether this mycelial extract exerts the same effect in human rhabdomyosarcoma A-204 and rat pheochromocytoma PC-12 cells. We found that the production of Aβ decreased in a dose-dependent manner in the presence of the mycelial extract and that the concentration of Aβ never exceeded 50 μg/ml. The presence of sAPP was detected in every culture medium to which the mycelial extract had been added and its concentration remained the same, regardless of the concentration of the extract used. Endogenous β-secretase <br>activity in A-204 and PC-12 cellular homogenates also decreased in the presence of this extract. These cells, in culture, were not susceptible to the cytotoxic activity of the mycelial extract.
Download PDF JM44(6)-12.pdf